AstraZeneca UK Limited

GPTKB entity

Properties (53)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Astra_Pharmaceuticals
gptkb:MedImmune
gptkbp:awards Best Workplaces 2020
Top Employer UK 2021
Global_Health_Partner_of_the_Year_2021
gptkbp:CEO gptkb:Pascal_Soriot
gptkbp:clinicalTrials gptkb:COVID-19_vaccine
cancer treatments
partnerships with research institutions
collaborations with hospitals
diabetes treatments
global clinical trial networks
gptkbp:communityEngagement health awareness campaigns
employee volunteer programs
support for local charities
gptkbp:employees over 14,000
gptkbp:founded 1999
gptkbp:headquarters gptkb:Cambridge,_England
https://www.w3.org/2000/01/rdf-schema#label AstraZeneca UK Limited
gptkbp:industry pharmaceuticals
gptkbp:investmentFocus expansion of manufacturing facilities
$1 billion in R&D annually
collaboration with biotech firms
gptkbp:market $150 billion (2021)
gptkbp:parentCompany gptkb:AstraZeneca_PLC
gptkbp:partnerships gptkb:Oxford_University
gptkb:University_of_Cambridge
gptkbp:patentCitation over 30,000 patents filed
gptkbp:philanthropy community health programs
support for education programs
donations to global health initiatives
gptkbp:products vaccines
oncology drugs
cardiovascular drugs
gptkbp:regulatoryCompliance WHO prequalification for vaccines
EMA_approvals_for_multiple_drugs
FDA_approvals_for_multiple_drugs
gptkbp:research_areas gptkb:Gothenburg_Research_Centre
gptkb:Gaithersburg_Research_Centre
gptkb:Cambridge_Research_Centre
Moscow_Research_Centre
gptkbp:researchFocus biopharmaceuticals
gptkbp:revenue $26 billion (2020)
gptkbp:subsidiary gptkb:AstraZeneca_Japan_K.K.
gptkb:AstraZeneca_India_Pvt._Ltd.
gptkb:AstraZeneca_Canada_Inc.
gptkb:AstraZeneca_Australia_Pty_Ltd.
AstraZeneca_PLC_USA
gptkbp:sustainabilityInitiatives diversity and inclusion programs
water conservation programs
carbon neutrality by 2025
gptkbp:website www.astrazeneca.com